Yes. Creatine supplementation can modestly raise serum creatinine without, by itself, meaning kidney injury. The reason matters: creatine and creatinine are part of the same metabolic pathway, while creatinine is also used as an indirect marker of kidney filtration. When creatinine production increases for reasons other than a true fall in filtration, the test can look worse than kidney function actually is.
That does not make every high creatinine result a “false alarm.” An abnormal value should be interpreted alongside medical history, trends over time, muscle mass, recent training, diet, medications, blood pressure, urine findings and, when needed, other filtration markers. The better question is not simply “does creatine harm the kidneys?” but “is this marker change accompanied by independent evidence of kidney dysfunction?”
Why creatine and creatinine can become confusing on lab tests
Creatine participates in the muscle’s rapid energy system, mainly as phosphocreatine. Some creatine and phosphocreatine is spontaneously converted into creatinine, which circulates in the blood and is eliminated mainly by the kidneys. By increasing the body’s creatine stores, supplementation can also increase the amount of creatinine produced even when the kidneys’ filtering capacity has not changed.
This is why creatinine is not a “pure kidney sensor.” It is influenced by filtration, but also by factors that change its production or concentration. The National Kidney Foundation lists creatine supplements, high muscle mass, recent high-intensity exercise and large amounts of cooked meat among factors that can raise creatinine without necessarily indicating worse kidney function. MedlinePlus likewise notes that one high result does not establish a diagnosis and may need repeat or additional testing.
What recent meta-analyses found
Evidence syntheses published in 2025 and 2026 help separate marker behavior from kidney function itself. A 2025 systematic review and meta-analysis found a small increase in creatinine with supplementation but no significant decline in glomerular filtration rate (GFR) across the pooled data. The authors also emphasized that studies lasting longer than one year remain sparse.
In 2026, a meta-analysis of randomized trials found an average increase of about 0.13 mg/dL in creatinine, with no significant difference in urea or estimated GFR between creatine and control groups. Another 2026 meta-analysis, including 26 studies and 1,036 participants, found higher creatinine and an apparent reduction in GFR when filtration was estimated with creatinine-based methods, but no significant difference when filtration was measured with Cr-EDTA clearance, a method that does not depend on muscle creatinine production.
The pattern is consistent: creatinine can rise and creatinine-based equations can estimate a lower GFR, while measurements less dependent on creatinine metabolism do not show the same deterioration. That supports the interpretation that part of the change reflects the marker rather than the kidney itself. Still, pooled averages cannot be used to declare that any individual abnormal result is harmless.
Why estimated GFR can look lower
Estimated GFR, or eGFR, is commonly calculated from serum creatinine together with demographic variables. If creatinine rises because production has increased, the equation may interpret that rise as reduced renal clearance and return a lower eGFR. In other words, one of the inputs has become less specific for that particular situation.
The KDIGO 2024 guideline explicitly recognizes that high muscle mass, intense sport or exercise, high-protein diets and creatine supplements can reduce the accuracy of estimates based only on creatinine. When accuracy matters, the guideline supports cystatin C in selected situations, combined creatinine-cystatin C equations or, for higher-stakes decisions, direct measurement of GFR.
What can rise, what it does not prove, and when to investigate
| What can rise or change | What that does not prove by itself | When it deserves closer evaluation |
|---|---|---|
| Serum creatinine after starting or using creatine | Kidney injury or chronic kidney disease | When the rise is substantial, keeps worsening, differs markedly from prior results, or comes with other abnormal findings |
| Creatinine-based eGFR can appear lower | That measured GFR fell by the same amount | When kidney function staging changes, medication dosing is affected, or an important clinical decision depends on the number |
| Creatinine after intense training, high meat intake or in people with high muscle mass | That the supplement is the only explanation | When competing factors, prior disease, dehydration, medications or symptoms require clinical context |
| A single result outside the reference range | A definitive diagnosis | When abnormalities persist on repeat testing or there are additional signs such as albuminuria, proteinuria, blood in urine, swelling or high blood pressure |
How to interpret the test without hiding a real problem
The best approach is to make the testing context explicit rather than trying to manipulate the number. Tell the healthcare professional that you use creatine, including the usual dose and how long you have taken it. It is also useful to report recent hard training, dietary changes, medications and any episode of dehydration or acute illness. Do not stop a medication or supplement solely to “normalize” a lab result without agreeing on the plan with the clinician who ordered the test.
If creatinine is higher than expected and there is doubt about the reliability of eGFR, the clinician may repeat testing under more stable conditions, review older results and consider markers that behave differently. Cystatin C is useful because it is less influenced by muscle mass; in many situations, an equation combining creatinine and cystatin C improves accuracy. However, cystatin C also has non-kidney determinants, so it should not be treated as an infallible test.
Urine tests add information as well. Urine albumin-to-creatinine ratio, proteinuria testing and urinalysis can look for evidence of kidney damage that serum creatinine alone cannot show. When a decision requires high precision—for example, certain medication doses or a specialist renal assessment—direct GFR measurement with an exogenous marker may be more appropriate.
When a creatinine increase should not automatically be blamed on creatine
Supplement use should not become the automatic explanation for every abnormal result. Seek professional evaluation when creatinine rises substantially or progressively, eGFR remains reduced, urine tests are abnormal, swelling appears, urine output drops markedly, blood pressure is high, persistent nausea or unusual weakness occurs, or there is known kidney disease or another condition that increases kidney risk.
Extra caution is appropriate for people with chronic kidney disease, a single kidney, a history of acute kidney injury, diabetes, hypertension or medications that may affect kidney function. Available studies include varied populations, but long-term data and evidence in some clinical groups remain limited. “No average decline was found in studies” does not mean “safe for every person at every dose.”
The practical point: a marker and kidney damage are not the same thing
Creatine can raise creatinine without kidney injury, and that rise can make creatinine-based eGFR appear lower. This is a recognized reason to interpret the test cautiously in muscular people, those who train intensely or those who use creatine. Recent meta-analyses support this distinction by showing marker increases without a corresponding deterioration in filtration measures that are less dependent on creatinine.
At the same time, there is no safe shortcut for labeling an abnormal result as “just creatine” without looking at the rest of the picture. Trends over time, urine findings, blood pressure, symptoms, medications, cystatin C and, when necessary, measured GFR help separate a marker shift from true kidney dysfunction.
This content is for informational purposes and does not replace individualized medical evaluation, especially when laboratory tests are abnormal or kidney disease is already known.
